Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Appili Therapeutics Inc. (APLIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.05820.0000 (0.00%)
At close: 11:11AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0582
Open0.0582
BidN/A x N/A
AskN/A x N/A
Day's Range0.0582 - 0.0582
52 Week Range0.0510 - 0.9020
Volume4,110
Avg. Volume13,585
Market Cap4.196M
Beta (5Y Monthly)1.08
PE Ratio (TTM)N/A
EPS (TTM)-0.3480
Earnings DateFeb 10, 2022 - Feb 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.78
  • Business Wire

    Appili Therapeutics Reports Fiscal Year 2022 Financial and Operational Results

    HALIFAX, Nova Scotia, June 29, 2022--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced its financial and operational results for the fiscal year ended March 31, 2022, and provided an update on the Company’s strategy for fiscal 2023. All figures are stated in Canadian dollars unless otherwise stated.

  • Business Wire

    Appili Therapeutics Announces Closing of Public Offering of $4,500,000

    HALIFAX, Nova Scotia, May 26, 2022--Appili Therapeutics Inc. (TSX: APLI) (the "Company" or "Appili") announced the closing of its previously announced public offering (the "Offering") of units (the "Units"). The Offering was made pursuant to an agency agreement, as amended, entered into between the Company, Bloom Burton Securities Inc. (the "Lead Agent") and Leede Jones Gable Inc. (collectively with the Lead Agent, the "Agents").

  • CNW Group

    IIROC Trade Resumption - APLI

    Trading resumes in:

Advertisement
Advertisement